Poolbeg Pharma (POLB) Competitors GBX 2.70 0.00 (-0.07%) As of 04/17/2025 11:22 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock POLB vs. SBTX, TRX, COS, C4XD, DDDD, FUM, OKYO, SAR, AOR, and OPTIShould you be buying Poolbeg Pharma stock or one of its competitors? The main competitors of Poolbeg Pharma include SkinBioTherapeutics (SBTX), Tissue Regenix Group (TRX), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Futura Medical (FUM), OKYO Pharma (OKYO), Sareum (SAR), AorTech International (AOR), and OptiBiotix Health (OPTI). These companies are all part of the "biotechnology" industry. Poolbeg Pharma vs. SkinBioTherapeutics Tissue Regenix Group Collagen Solutions plc (COS.L) C4X Discovery 4D pharma Futura Medical OKYO Pharma Sareum AorTech International OptiBiotix Health Poolbeg Pharma (LON:POLB) and SkinBioTherapeutics (LON:SBTX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, community ranking, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment. Do insiders & institutionals have more ownership in POLB or SBTX? 1.2% of Poolbeg Pharma shares are held by institutional investors. Comparatively, 16.6% of SkinBioTherapeutics shares are held by institutional investors. 24.7% of Poolbeg Pharma shares are held by company insiders. Comparatively, 20.4% of SkinBioTherapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is POLB or SBTX more profitable? Poolbeg Pharma has a net margin of 0.00% compared to SkinBioTherapeutics' net margin of -237.95%. Poolbeg Pharma's return on equity of -32.56% beat SkinBioTherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Poolbeg PharmaN/A -32.56% -21.33% SkinBioTherapeutics -237.95%-115.86%-61.18% Does the MarketBeat Community favor POLB or SBTX? SkinBioTherapeutics received 47 more outperform votes than Poolbeg Pharma when rated by MarketBeat users. Likewise, 60.26% of users gave SkinBioTherapeutics an outperform vote while only 0.00% of users gave Poolbeg Pharma an outperform vote. CompanyUnderperformOutperformPoolbeg PharmaOutperform VotesNo VotesUnderperform Votes1100.00% SkinBioTherapeuticsOutperform Votes4760.26% Underperform Votes3139.74% Which has better valuation & earnings, POLB or SBTX? SkinBioTherapeutics has higher revenue and earnings than Poolbeg Pharma. SkinBioTherapeutics is trading at a lower price-to-earnings ratio than Poolbeg Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPoolbeg PharmaN/AN/A-£4.50B-£851.820.00SkinBioTherapeutics£1.56M31.25-£3.71M-£1.63-13.13 Does the media refer more to POLB or SBTX? In the previous week, Poolbeg Pharma's average media sentiment score of 0.00 equaled SkinBioTherapeutics'average media sentiment score. Company Overall Sentiment Poolbeg Pharma Neutral SkinBioTherapeutics Neutral Which has more risk and volatility, POLB or SBTX? Poolbeg Pharma has a beta of 2.11, suggesting that its stock price is 111% more volatile than the S&P 500. Comparatively, SkinBioTherapeutics has a beta of 2.01, suggesting that its stock price is 101% more volatile than the S&P 500. SummaryPoolbeg Pharma and SkinBioTherapeutics tied by winning 6 of the 12 factors compared between the two stocks. Get Poolbeg Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for POLB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POLB vs. The Competition Export to ExcelMetricPoolbeg PharmaBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£13.87M£121.00M£5.30B£2.48BDividend YieldN/A3.75%5.45%4.96%P/E Ratio0.003.0521.86129.75Price / SalesN/A4,228.83380.52232,042.22Price / Cash2.1113.1938.2628.07Price / Book0.0034.276.454.43Net Income-£4.50B-£91.73M£3.22B£5.83B1 Month Performance-6.48%-5.12%-9.71%-1.34%1 Year Performance-74.55%83.94%11.51%117.27% Poolbeg Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POLBPoolbeg PharmaN/AGBX 2.70-0.1%N/A-74.2%£13.87MN/A0.0012Gap DownSBTXSkinBioTherapeuticsN/AGBX 21+5.0%N/A+129.1%£47.97M£1.56M-12.9211TRXTissue Regenix GroupN/AGBX 36-1.4%N/A-40.8%£32.46M£31.98M-37.17120COSCollagen Solutions plc (COS.L)N/AN/AN/AN/A£30.99M£4.01M-8.283,350C4XDC4X DiscoveryN/AN/AN/AN/A£30.27M£24.68M300.0049High Trading VolumeDDDD4D pharmaN/AN/AN/AN/A£30.05M£718,000.00-1.08106FUMFutura MedicalN/AGBX 8.70-3.6%N/A-74.9%£27.11M£8.68M-7.1712Earnings ReportGap DownOKYOOKYO PharmaN/AN/AN/AN/A£23.24MN/A-140.007Gap DownSARSareumN/AGBX 17.40-5.9%N/A-36.4%£21.74MN/A-4.123,211Gap DownAORAorTech InternationalN/AN/AN/AN/A£19.99M£539,000.00-33.383OPTIOptiBiotix HealthN/AGBX 18.44+2.4%N/A+2.8%£18.06M£590,009.23-5.841Gap UpHigh Trading Volume Related Companies and Tools Related Companies SBTX Competitors TRX Competitors COS Competitors C4XD Competitors DDDD Competitors FUM Competitors OKYO Competitors SAR Competitors AOR Competitors OPTI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:POLB) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poolbeg Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Poolbeg Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy POLB Stock Free POLB Stock Alerts